HOXD4 and glioblastoma: in survival analysis demonstrated that HOXD4 expression were a remarkable prognostic factor in 1p/19q intact subgroup of GBM (Figure 4Cp=0.001), but not in 1p/19q co-deletion subgroup (Figure 4Dp=0.090).